Table 3.
CD3 | CD8 | CD4 | CD20 | CD68 | CD163 | PD-L1 tumor | PD-L1 immune | PD-1 immune | |
---|---|---|---|---|---|---|---|---|---|
CD3 | 1 | 0.81** | 0.51** | 0.29 | 0.45* | 0.53** | 0.43** | 0.50** | 0.47** |
CD8 | 1 | 0.51** | 0.24 | 0.36 | 0.38 | 0.52** | 0.46** | 0.55** | |
CD4 | 1 | 0.13 | 0.23 | 0.32 | 0.35* | 0.34* | 0.37* | ||
CD20 | 1 | 0.16 | 0.23 | 0.05 | 0.14 | 0.32 | |||
CD68 | 1 | 0.90** | 0.23 | 0.20 | 0.38 | ||||
CD163 | 1 | 0.27 | 0.28 | 0.42 | |||||
PD-L1 tumor | 1 | 0.66** | 0.31 | ||||||
PD-L1 immune | 1 | 0.39** | |||||||
PD-1 immune | 1 |
**p < .0001; *p < .001.